Factor V Leiden mutation in Sneddon syndrome

Lupus

Volumn 12, Issue 5, 2003, Pages 406-408

  Besnier, R ^a   Frances C ^a   Ankri, A ^a   Aiach, M ^b   Piette, J C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Antiphospholipid antibodies; Factor V Leiden; Genetics; Sneddon syndrome; Stroke

Indexed keywords

ANTITHROMBIN III; BETA2 GLYCOPROTEIN 1 ANTIBODY; BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PROTEIN C; PROTEIN S;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC SUSCEPTIBILITY; HEMOSTASIS; HUMAN; LIVEDO RETICULARIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SNEDDON SYNDROME; THROMBOGENESIS;

ADOLESCENT; ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; FACTOR V; FEMALE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; PREVALENCE; PROTEIN C; SNEDDON SYNDROME;

EID: 0038579714     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203303lu386sr     Document Type: Article

References (15)

1. Sneddon IB. Cerebrovascular lesions and livedo reticularis. Br J Dermatol 1965; 77: 180-185.
2. Francès C, Papo T, Wechsler B, Laporte JL, Biousse V, Piette JC. Sneddon syndrome with or without antiphospholipid antibodies: a comparative study in 46 patients. Medecine (Baltimore) 1999; 78: 209-219.
3. Zelger B, Sepp N, Stockhammer G et al. Sneddon's syndrome. A long term follow up of 25 patients. Arch Dermatol 1993; 129: 437-447.
4. Kalashnikova LA, Nasonov EL, Borisenko VV et al. Sneddon's syndrome: cardiac pathology and antiphospholipid antibodies. Clin Exp Rheumatol 1991; 9: 357-361.
5. Alhenc-Gelas M, Gandrille S, Aubry ML, Emmerich J, Flessinger JN, Aiach M. Unexplained thrombosis and factor V Leiden mutation. Lancet 1994; 344: 555-556.
6. Pinol Aguade J, Ferrandiz C, Ferrer Roca O, Ingelmo M. Livedo reticularis y accidentes cerebro-vasculares. Med Cutan Ibero Lat Am 1975; 4: 257-266.
7. Gualtieri RJ, Walton GD. Activated protein C resistance and Sneddon's syndrome. Am J Med 1999; 107: 293.
8. Mayou SC, Kovacs IB, Kirby JD. Hemostatic abnormalities in Sneddon's syndrome. Angiology 1992; 4: 342-349.
9. Aznar J, Villa P, Yaya R, Ferrando F, Estelles A, Valles J, Santos MT. Sneddon's syndrome and antiphospholipid antibodies. Thromb Res 1993; 69: 555-560.
10. Devos J, Bulcke J, Degreef H, Michielsen B. Sneddon's syndrome: generalised livedo reticularis and cerebrovascular disease. Dermatology 1992; 185: 296-299.
11. Donnet A, Khalil R, Terrier G, Koeppel MC, Njee BT, Aillaud ME Cerebral infarction, livedo reticularis and familial deficiency in antithrombin III. Stroke 1992; 23: 611-612.
12. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-1134.
13. Margaglione M, D'Andrea G, Giuliani N et al. Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden. Arterioscler Thromb Vasc Biol 1999; 19: 1751-1756.
14. Kenet G, Sadetzki S, Murad H et al. Factor V leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 2000; 31: 1283-1288.
15. Francès C, Piette JC. The mystery of Sneddon syndrome: relationship with antiphospholipid syndrome and systemic lupus erythematosus. J Autoimmun 2000; 15: 139-143.